Sign in

    Vivek Shri

    Research Analyst at Goldman Sachs

    No valid professional profile information is available for Vivek Shri at Goldman Sachs. After thorough review of accessible sources, there is no evidence of Vivek Shri holding an analyst or senior research position at Goldman Sachs, nor of their coverage of specific companies, performance metrics, professional credentials, or career timeline. None of the cited sources—including employee directories, career profiles, or alumni references—yield an analyst named Vivek Shri with relevant details at Goldman Sachs.

    Vivek Shri's questions to REGAL REXNORD (RRX) leadership

    Vivek Shri's questions to REGAL REXNORD (RRX) leadership • Q4 2024

    Question

    Vivek Shri of Goldman Sachs questioned the rationale for the Q1 organic sales decline in IPS, given positive orders and prior-quarter pushouts. He also sought confirmation on the steep Q4 2025 margin expansion and its primary drivers.

    Answer

    CEO Louis Pinkham reiterated that the Q1 IPS forecast is based on the current shippable backlog and book-ship assumptions, which show pressure despite underlying momentum and share gains. CFO Rob Rehard confirmed the target of exiting 2025 near a 25% EBITDA margin is correct, with the significant year-over-year expansion in Q4 driven primarily by favorable sales mix in the higher-margin AMC and IPS segments.

    Ask Fintool Equity Research AI